The Q2 results are due on Thursday and EPS is expected to be around Rs 7.00. This will give an annual EPS of around Rs 30 and at Rs 550 it trades at a PE of 18.33.
This is a good price to enter for the long term in a sector which is inelastic and hold tremendous potential as health care sector is expected to explode in the next 3-5 years.
The promoters have alloted themselves 15.50 lac shares at Rs 497 in April 2009 which is a good sign.
Enter around current levels for a safe ride!! A Bonus or a Stock split too could be around the corner as the company celebrates 25 years!
Results declared but below expectations. OPM has increasedby 2 basis points but other expenses/ tax / depreciation have increased more than expected.
Scrip could be range bound for now until some corporate action or improvement in market sentiment.
Still a HOLD and medium ot long term view intact.